FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

23639811000001109: Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Sep 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    77268901000001117 Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    77269001000001110 Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) Is a Rivastigmine 9.5mg/24hours transdermal patches false Inferred relationship Existential restriction modifier
    Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) Has active ingredient Rivastigmine false Inferred relationship Existential restriction modifier
    Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) Has specific active ingredient Rivastigmine false Inferred relationship Existential restriction modifier
    Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) Has dispensed dose form Prolonged-release transdermal patch false Inferred relationship Existential restriction modifier
    Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) Is a Actual medicinal product false Inferred relationship Existential restriction modifier
    Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) Has manufactured dose form Prolonged-release transdermal patch false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) 30 patch Has AMP False Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start